Plinabulin
- Generic Name
- Plinabulin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C19H20N4O2
- CAS Number
- 714272-27-2
- Unique Ingredient Identifier
- 986FY7F8XR
- Indication
Investigated for use/treatment in cancer/tumors (unspecified).
- Associated Conditions
- -
- Associated Therapies
- -
BTCRC-LUN17-127
A Big Ten Cancer Research Consortium study on plinabulin combined with nivolumab and ipilimumab for recurrent small cell lung cancer was published in Lung Cancer Journal. The study, BTCRC-LUN17-127, found the combination tolerable at 30 mg/m², though median progression-free survival was 1.6 months, below the target of 3.5 months. Some patients showed prolonged response.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath